The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Kelley Kenneth J since 2007.
This trader's CIK number is 1291219.
At the time of last reporting, Kelley Kenneth J was the Officer of Halozyme Therapeutics, Inc.. (stock ticker symbol HALO).
Also see all insider trading activities at Halozyme Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | HALO | 0 | $0 | 15,000 | $685,975 | 0 | $0 |
| 2020 | HALO | 52,629 | $748,700 | 86,549 | $3,555,844 | 0 | $0 |
| 2015 | HALO | 0 | $0 | 60,000 | $1,033,400 | 20,000 | $153,099 |
| 2012 | HALO | 40,000 | $263,780 | 0 | $0 | 0 | $0 |
| 2007 | HALO | 0 | $0 | 250,000 | $2,265,071 | 235,000 | $795,116 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-03-01 | HALO | Sale | 5,000 | 45.67 | 228,365 |
| 2021-02-01 | HALO | Sale | 5,000 | 48.39 | 241,945 |
| 2021-01-04 | HALO | Sale | 5,000 | 43.13 | 215,665 |
| 2020-12-07 | HALO | Sale | 35,086 | 41.00 | 1,438,526 |
| 2020-12-02 | HALO | Sale | 31,792 | 41.00 | 1,303,472 |
| 2020-11-25 | HALO | Sale | 9,671 | 41.50 | 401,346 |
| 2020-11-27 | HALO | Sale | 10,000 | 41.25 | 412,500 |
| 2020-03-19 | HALO | Buy | 52,629 | 14.23 | 748,700 |
| 2015-08-28 | HALO | Option Ex | 10,000 | 10.37 | 103,699 |
| 2015-06-18 | HALO | Sale | 20,000 | 21.00 | 420,000 |
| 2015-06-05 | HALO | Option Ex | 10,000 | 4.94 | 49,400 |
| 2015-03-05 | HALO | Sale | 40,000 | 15.34 | 613,400 |
| 2012-08-27 | HALO | Buy | 20,000 | 5.70 | 113,980 |
| 2012-05-14 | HALO | Buy | 20,000 | 7.49 | 149,800 |
| 2007-05-25 | HALO | Option Ex | 22,500 | 3.45 | 77,625 |
| 2007-05-25 | HALO | Sale | 22,500 | 10.27 | 231,052 |
| 2007-05-18 | HALO | Sale | 15,000 | 10.55 | 158,325 |
| 2007-05-07 | HTI | Option Ex | 12,500 | 4.10 | 51,249 |
| 2007-05-07 | HTI | Sale | 12,500 | 10.42 | 130,237 |
| 2007-04-30 | HTI | Option Ex | 25,000 | 4.10 | 102,499 |
| 2007-04-30 | HTI | Sale | 25,000 | 10.32 | 258,075 |
| 2007-04-23 | HTI | Option Ex | 25,000 | 4.10 | 102,499 |
| 2007-04-23 | HTI | Sale | 25,000 | 8.89 | 222,300 |
| 2007-04-16 | HTI | Option Ex | 25,000 | 4.10 | 102,499 |
| 2007-04-16 | HTI | Sale | 25,000 | 9.07 | 226,700 |
| 2007-04-09 | HTI | Option Ex | 25,000 | 4.10 | 102,499 |
| 2007-04-09 | HTI | Sale | 25,000 | 8.46 | 211,625 |
| 2007-04-02 | HTI | Option Ex | 25,000 | 4.10 | 102,499 |
| 2007-04-02 | HTI | Sale | 25,000 | 8.05 | 201,375 |
| 2007-03-26 | HTI | Option Ex | 25,000 | 2.05 | 51,249 |
| 2007-03-26 | HTI | Sale | 16,262 | 8.43 | 137,088 |
| 2007-03-27 | HTI | Sale | 8,238 | 8.31 | 68,498 |
| 2007-03-27 | HTI | Sale | 500 | 8.39 | 4,196 |
| 2007-03-19 | HTI | Option Ex | 25,000 | 2.05 | 51,249 |
| 2007-03-19 | HTI | Sale | 25,000 | 8.71 | 217,700 |
| 2007-03-14 | HTI | Option Ex | 25,000 | 2.05 | 51,249 |
| 2007-03-14 | HTI | Sale | 25,000 | 7.92 | 197,900 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kelley Kenneth J (Officer of Halozyme Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.